News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,523 Results
Type
Article (87411)
Company Profile (759)
Press Release (772328)
Multimedia
Podcasts (171)
Webinars (28)
Section
Business (233047)
Career Advice (4139)
Deals (39793)
Drug Delivery (134)
Drug Development (91245)
Employer Resources (203)
FDA (18277)
Job Trends (17399)
News (397371)
Policy (39924)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (145)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (231)
Approvals (18293)
Artificial intelligence (484)
Autoimmune disease (69)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (158)
Biotechnology (484)
Bladder cancer (124)
Brain cancer (52)
Breast cancer (481)
Cancer (3843)
Cardiovascular disease (337)
Career advice (3556)
Career pathing (38)
CAR-T (245)
CDC (57)
Cell therapy (678)
Cervical cancer (32)
Clinical research (75349)
Collaboration (1370)
Company closure (4)
Compensation (931)
Complete response letters (59)
COVID-19 (2954)
CRISPR (81)
C-suite (582)
Cystic fibrosis (133)
Data (4318)
Decentralized trials (2)
Denatured (60)
Depression (109)
Diabetes (450)
Diagnostics (7089)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (230)
Drug pricing (188)
Drug shortages (36)
Duchenne muscular dystrophy (202)
Earnings (98773)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132886)
Executive appointments (985)
FDA (20705)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1244)
Gene editing (173)
Generative AI (48)
Gene therapy (545)
GLP-1 (1016)
Government (5380)
Grass and pollen (7)
Guidances (338)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (240)
Immuno-oncology (20)
Indications (52)
Infectious disease (3188)
Inflammatory bowel disease (185)
Inflation Reduction Act (15)
Influenza (94)
Intellectual property (186)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (15)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (547)
Lymphoma (262)
Machine learning (29)
Management (66)
Manufacturing (635)
MASH (138)
Medical device (14865)
Medtech (14888)
Mergers & acquisitions (22740)
Metabolic disorders (1146)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2705)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (57)
Obesity (555)
Opinion (311)
Ovarian cancer (127)
Pain (163)
Pancreatic cancer (168)
Parkinson's disease (239)
Partnered (30)
Patents (413)
Patient recruitment (304)
Peanut (57)
People (66240)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23236)
Phase II (32715)
Phase III (24612)
Pipeline (2678)
Policy (295)
Postmarket research (3554)
Preclinical (10488)
Press Release (72)
Prostate cancer (196)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (664)
Real estate (7421)
Recruiting (78)
Regulatory (27968)
Reports (65)
Research institute (2688)
Resumes & cover letters (651)
Rett syndrome (15)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (206)
Series B (155)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (95)
The Weekly (109)
Vaccines (1039)
Venture capital (66)
Weight loss (393)
Women's health (58)
Worklife (21)
Date
Today (150)
Last 7 days (575)
Last 30 days (2559)
Last 365 days (33543)
2025 (26059)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50933)
Australia (8954)
California (9367)
Canada (2841)
China (883)
Colorado (400)
Connecticut (420)
Delaware (261)
Europe (117045)
Florida (1376)
Georgia (314)
Hawaii (3)
Idaho (67)
Illinois (808)
India (50)
Indiana (458)
Iowa (19)
Japan (314)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1270)
Massachusetts (7058)
Michigan (311)
Minnesota (560)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (77)
New Jersey (2597)
New Mexico (32)
New York (2551)
North Carolina (1407)
North Dakota (10)
Northern California (4217)
Ohio (294)
Oklahoma (22)
Oregon (50)
Pennsylvania (1957)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (48)
South Dakota (1)
Southern California (3584)
Tennessee (149)
Texas (1473)
United States (34688)
Utah (280)
Virginia (247)
Washington D.C. (83)
Washington State (811)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
There are 860,523 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Incyte Canada Announces Health Canada approval of Opzelura® (Ruxolitinib) Cream for the Treatment of Atopic Dermatitis in Children Ages 2-11
October 16, 2025
·
8 min read
Press Releases
Sogroya® (somapacitan injection) now available in Canada as the first and only once-weekly treatment for both children and adults living with growth hormone deficiency
October 16, 2025
·
5 min read
Press Releases
Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors
October 16, 2025
·
4 min read
Press Releases
Marengo Therapeutics to Present Key Pipeline Updates at 2025 SITC Annual Meeting and Reveal First Asset from TriSTAR™ Platform Targeting Nectin-4
October 16, 2025
·
5 min read
Press Releases
Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes
October 16, 2025
·
9 min read
Press Releases
Sitryx to participate in upcoming November 2025 investor conferences
October 16, 2025
·
1 min read
Press Releases
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs
October 16, 2025
·
4 min read
Press Releases
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
October 16, 2025
·
13 min read
Press Releases
Repligen to Report Third Quarter 2025 Financial Results
October 16, 2025
·
2 min read
Press Releases
Endo Announces Peyronie’s Disease Presentation at the North Central Section of the American Urological Association
October 16, 2025
·
9 min read
1 of 86,053
Next
